Stock listing

Lang & Schwarz:A2DG49 KalVista Pharmaceuticals, Inc. Aktie

German listing (Lang & Schwarz) of KalVista Pharmaceuticals, Inc. · home listing NASDAQ:KALV

Follow KalVista Pharmaceuticals, Inc. into a list and get an email when it puts out news.

KalVista Pharmaceuticals, Inc. logo
Ticker
Lang & Schwarz:A2DG49
Asset type
Stock
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Kalvista Pharmaceuticals (NASDAQ:KALV) Q3 2025 Earnings Call

    Tue, Nov 11, 2025 · 8:30 AM ET

    Watch Transcript

  • Kalvista Pharmaceuticals (NASDAQ:KALV) Q2 2025 Earnings Call

    Thu, Sep 11, 2025 · 8:30 AM ET

    Watch Transcript

Latest news

Chiesi Group Completes Acquisition of KalVista Pharmaceuticals

Jun 11, 2026

KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema

May 28, 2026

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio

Apr 29, 2026

KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026

KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference

Mar 30, 2026

KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

Mar 25, 2026

KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference

Mar 20, 2026

KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026

Mar 18, 2026

KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)

Mar 2, 2026

KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline

Feb 18, 2026

All KalVista Pharmaceuticals, Inc. news

Decks

KalVista Pharmaceuticals, Inc. on 6ix

News releases
19 in the last 12 months · 163 in all · newest Jun 11, 2026 · oldest 2019
Calls
2 calls with a replay · 2 with a transcript · latest Nov 11, 2025
Decks
16 decks · latest Jan 8, 2026

Where KalVista Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:KALV · Home listingNASDAQUnited StatesUSD
gettex:4XC1gettexGermanyEUR
LS Exchange:A2DG49LS ExchangeGermanyEUR
Tradegate:4XC1TradegateGermanyEUR
BOATS:KALVBOATSUnited StatesUSD
Lang & Schwarz:A2DG49 · This pageLang & SchwarzGermanyEUR
Frankfurt:4XC1FrankfurtGermanyEUR
Munich:4XC1MunichGermanyEUR
Dusseldorf:4XC1DusseldorfGermanyEUR
Hamburg:4XC1HamburgGermanyEUR
Stuttgart:4XC1StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about KalVista Pharmaceuticals, Inc.